RxDoctor Payments Data

Anna Rodis

Adult Health · Philadelphia, PANPI 1700534401

Payments from drug & device makers

$1,683in general payments, 2019–2025

Across 89 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$406
  • Novo Nordisk$335
  • AstraZeneca$193
  • Lilly USA, LLC$174
  • Pfizer$170
  • GSK$108
  • plus $297 from 9 others

What the payments were for

  • Food & beverage$1,683100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,683 in reported general payments places this provider in the 75th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$23,402
Medicare patients
78
Services billed
418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$80,474
EliquisApixaban14$25,226
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$21,454
FarxigaDapagliflozin Propanediol12$20,798
JardianceEmpagliflozin11$8,647
Atorvastatin Calcium203$1,998
Levothyroxine Sodium118$1,416
Omeprazole57$1,300
SynthroidLevothyroxine Sodium12$1,252
Rosuvastatin Calcium75$1,011
Nebivolol Hcl11$845
Gabapentin37$771
Albuterol Sulfate HfaAlbuterol Sulfate29$676
Lisinopril115$634
Metformin Hcl59$490

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$335$80,47472 claims
PfizerEliquis$170$25,22614 claims
GSKTrelegy Ellipta$108$21,45432 claims
AstraZenecaFarxiga$193$20,79812 claims
Boehringer IngelheimJardiance$44$8,64711 claims
AbbVieSynthroid$406$1,25212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →